Aim: This study aimed at calibrating a new set of GR-200A thermoluminescent dosimeters (TLDs) in low and medium kilovoltage energy photon therapy beams and in a diagnostic beam of known beam quality, in order to determine their response and to establish if the same set of TLDs could be used across both environments for in-vivo dosimetry purposes.
DEFINITION OF TECHNICAL TERMS, ACRONYMS AND SYMBOLS

AAPM: American Association of Physicists in Medicine
Absorbed Dose: The energy absorbed per unit mass of the irradiated material 12 .
Annealing: The thermal treatment needed to erase the irradiation memory from a TLD. In this study, GR-200A TLDs were calibrated in low and medium energy photon therapy beams and in a diagnostic beam of known beam quality, in order to determine their response and to establish if the same set of TLDs could be used across both kilovoltage environments for in-vivo dosimetry purposes.
Background
Radiation Oncology employs ionizing radiation in the treatment of cancerous cells. Two methods (teletherapy and brachytherapy) are used to deliver the ionizing radiation to the target volume. Teletherapy is a term used to describe treatments in which the source of radiation is distant from the patient 12 . Brachytherapy is a method of treatment in which radioactive sources are used to deliver radiation at a short distance by interstitial or surface applications 12 . A quality assurance programme ensures that all treatment facilities used in radiotherapy are properly checked for accuracy or consistency, that all radiation mechanical and dosimetric tests.
Dosimetry deals with methods for the quantitative determination of absorbed dose in a given medium by directly or indirectly ionizing radiation 18 . A dosimeter is the device or system that measures the absorbed dose either directly or indirectly 18 . In order for an instrument to function as a dosimeter, it must possess at least one physical property of the measured dosimetric quantity. Different types of dosimeters are used currently for the measurement of absorbed dose and these include ionization chambers, semiconductor dosimeters (e.g. diodes), film, alanine, gel, and thermoluminescent dosimeters. While some of these dosimeters are reusable (ionization chamber, TLDs, diodes) others are not (films, gels, and alanine) 18 . These dosimeters are calibrated from time to time to ensure consistency.
TLDs and their properties
Description of TLDs
Thermoluminescent dosimeters are crystalline materials that store absorbed energy from exposure to radiation and release it as visible light when exposed to heat. TLDs have been used widely for different studies (in-vivo, in-phantom and environmental) 14, 15, 17 .
TLDs have the advantage of long-term stability 6, 13 and low cost of acquisition compared to other detectors such as diodes 11 . TLDs are used for in-vivo dosimetry primarily because of their small size. TL materials are available in various forms i.e. chips, ribbons, discs, rods and powder.
Interaction of radiation with TLDs
The interaction process between radiation and TLDs occurs in two stages. The processes'
occurring within these two stages is diagrammatically shown in figure 1. Cu, Al 2 O 3 : C, CaSO 4 : Dy, CaF 2 : Dy) 8, 13 . Of these TL materials, the most commonly used ones are the lithium fluorides 2, 3, 5, 6, . Table 1 shows different TL materials and their characteristics. uniformity. Their study showed that there was a 40 % over response of the TLDs when they were calibrated using an X-ray source (diagnostic energy range). However, the type of TLD material may have influenced the over response as studies have shown that TLD-100 is not suited to low energy photon beam dosimetry 6, 7 . Duggan 6 compared the response of different TL materials in low energy photon therapy beams and showed that GR200A had a better response than TLD-100. Glenin 7 also showed in a separate report that GR200A releases 34 times more light than TLD-100 when calibrated in low energy photon therapy beams.
Factors affecting the response of TLDs
The following are some of the factors that may affect the response of TLDs in the measurement of absorbed dose.
• The response of TLDs varies from one material to another 8, 13 .
• The fading period for TLDs differs between materials as indicated in Table 1 and this may affect the response of TLDs.
• Handling procedures 8 (such as keeping TLDs under subdued ultra-violet environment during measurement, use of vacuum tweezers for transferring TLDs), if not followed properly during calibration of TLDs, may affect response.
• Intrinsic response of the TLD reader may also affect the general response of the dosimeter 16, 20 .
• The annealing used to prepare the TLDs for reuse may also influence the measurements as annealing regimes are different from one TL material to another 8 .
TLD dosimetry is regarded as a 'black art' because to some, it produces excellent results with great accuracy but to others, all attempts seem to fail 11 . It is therefore necessary for each Radiotherapy centre to embark in a full dosimetric study for the calibration of TLDs before they are used clinically for in-vivo dosimetry.
Research objective
1. To calibrate a set of new GR200A TLDs (LiF: Mg, Cu, P) needed for in-vivo dosimetry in a range of kilovoltage therapy beams and in a diagnostic beam.
To compare the absorbed dose obtained from 4 different beam qualities to an
independently confirmed reference dose.
3. To establish if the same set of TLDs could be used across both kilovoltage environments for in-vivo dosimetry purposes.
MATERIALS AND METHODS
Study materials
Detectors
20 TLDs manufactured by FIMEL, France were used for this study. The TLDs were in the form of circular chips with dimensions 4.5 mm diameter and 0.8 mm thickness. The
TLDs were kept in a subdued ultra-violet environment during storage. The same set of
TLDs was used for all the different energies. The 20 TLDs were used both as calibration dosimeters and field dosimeters. This TL material was chosen for this study because of its availability, its high response in low energy photon beams and its proven use in highenergy beams for clinical in-vivo dosimetry. 6, 7, 17 . The set of TLDs were arranged in an annealing pan prior to annealing for individual identification and then transferred to a plastic holder prior to irradiation to preserve the order of identification as shown in TM77334 ionization chamber and T10008 electrometer that were used to confirm the output of the orthovoltage machine and the radiotherapy simulator respectively.
Annealing materials
A type PCL 3 Oven manufactured by PTW-Freiburg, Germany was used to anneal the TLDs. A photograph of the oven is shown in Figure 5 . The parameters for the PTW 30001 Cylindrical ionization chamber TM77334 ionization chamber T10008 electrometer
PTW 10008 electrometer
Temperature Time Profile (TTP) were set as indicated in the TL Detector User manual 8 and are shown in Table 3 . An appropriate TTP for the TL material being used was set according to the parameters shown in Table 3 . Figure 6 .
Figure 6:
The Vacuum tweezer DYMAX 30 that was used to transfer the TLDs during measurement.
Reader
The response of the TLDs was read using the Reader type LTM. The automatic mode of The Reader used is shown in Figure 7 .
Figure 7:
The reader type LTM that was used to read the TLDs
The Oven and the Reader were connected to a dedicated personal computer that used Theldo and WinRems software for initiating the annealing and reading programs respectively.
Radiation facilities
A calibrated orthovoltage machine manufactured by Gulmay, Germany was used to deliver 1.00 Gy to the TLDs. A calibrated Toshiba LX40 radiotherapy simulator, Japan was used to deliver a known diagnostic dose of 1.00 cGy to the TLDs. The TLDs were placed on the surface of a 30 x 30 x 17.6 cm³ Polymethylmethacrylate (PMMA) phantom during both irradiations. A radiographic film was used to check the dose uniformity of the absorbed dose delivered.
TLD in reading position Planchet
Data collection procedures
Absorbed dose delivery verification procedure at orthovoltage
The absorbed dose delivered by the orthovoltage machine was determined using the inphantom method described in the American Association of Physicists in Medicine Task
Group 61 19 . The chamber was placed at a depth of 2 cm. A 10 x 10 cm² applicator was used to define the field size at 50 cm SSD. Different filters with varying thicknesses were used to harden the beams. The machine monitor unit (time) was calculated to deliver a dose of 1.00 Gy at the surface. A photograph of the experimental set-up is shown in Figure 8 . 
Where, M is the electrometer reading (charge) corrected for temperature and pressure.
N k is air-kerma calibration factor, for a specified X ray beam quality.
P Q,chamb is the overall chamber correction factor that accounts for the change due to the change in beam quality between calibration and measurement and to the perturbation of the photon fluence at the point of measurement by the chamber, and the chamber stem, which is dimensionless.
P sheath is the correction for photon absorption and scattering in the waterproofing sleeve.
is the mean mass-energy absorption coefficient ratio for water to air averaged over the photon spectrum at the reference point in water in the absence of the chamber.
The absorbed dose at the depth of 2 cm was then converted to absorbed dose at the surface of the phantom by using the percentage depth dose (PDD). This was done for the 95 kV p (3.00 mm Al HVL), 180 kV p (1.00 mm Cu HVL), and 300 kV p (3.00 mm Cu HVL) therapy beams.
Confirmation of reference absorbed dose at the simulator
The reference absorbed dose to be delivered to the TLDs in the diagnostic beam was determined using the in-phantom formalism described in IAEA Technical Report Series 457 for calculating the entrance surface air kerma rate 13 . The fluoroscopic mode of the radiotherapy simulator was used. The TLDs were exposed to an 80 kV P beam of 2.97 mm The entrance surface air kerma rate was calculated using the formula;
Where;
M is the electrometer reading (charge), with the centre of the sensitive air cavity placed at the surface, corrected for temperature and pressure. B w is the back scatter factor in terms of air kerma for water B PMMA is the back scatter factor in terms of air kerma for PMMA.
The entrance surface air kerma rate was obtained in cGy (The term entrance surface air kerma rate was used to represent the absorbed dose in accordance with the protocol) 13 .
TLD calibration procedures at orthovoltage
After irradiation, the TLD responses were read and stored in a database for calibration.
EECs for the calibration dosimeters were generated from the database. Only TLDs that
were within the ± 10 % accepted range for calibration dosimeters were selected for the calibration of the reader. The RCF was generated from the data base by applying the EECs of calibration dosimeters generated above. The RCF was then stored for future use.
The field dosimeter ECCs were generated by applying the RCF and setting the ECC range to the ± 20 % accepted range for field dosimeters. All TLDs that were within the accepted range were kept for calibration while others (marked as bad dosimeters) were removed from the batch. The absorbed dose measured was obtained by applying the RCF and the individual ECCs of the TLDs. The absorbed dose obtained was then stored for analysis. After the calibration process had been completed, the TLDs were irradiated again to an arbitrary absorbed dose of 2.00 Gy and read.
TLD calibration procedures at the simulator
The data collection procedures were repeated with the same set of TLDs for an absorbed dose of 1.00 cGy from the simulator. After the calibration process had been completed, the TLDs were irradiated to an arbitrary absorbed dose of 2.00 cGy and read.
RESULTS AND DISCUSSION
Absorbed dose delivery verification results at orthovoltage
The absorbed dose at the surface derived from the ionization chamber measurement at the 3 kilovoltage therapy beams, was 1.00 ± 0.01 Gy.
TLD calibration results at orthovoltage
At the start of the experiment, a calibration was performed in the 95 kV p therapy beam to generate an RCF file. 20 TLDs were irradiated to known absorbed doses in the 180 kV p and 300 kV p therapy beams. Only 40 % of the TLDs were within ± 10 % of the delivered absorbed dose in the 180 kV p beam and only 25 % in the 300 kV p beam. Separate RCF file were therefore generated for each beam quality.
kV p
7 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were therefore not used as calibration dosimeters. The RCF value was calculated to be 0.39 nC / Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered, except TLD D3 as shown in Table 4 . For the 2.00 Gy irradiation, all TLDs were within ± 10 %. 180 kV p 9 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were therefore not used as calibration dosimeters. The RCF value was calculated to be 0.30 nC / Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered as shown in Table 5 . For the 2.00 Gy irradiation, all TLDs were within ± 10 %. 300 kV p 9 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were therefore not used as calibration dosimeters. The RCF value was calculated to be 0.24 nC / Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered as shown in Table 6 . For the 2.00 Gy irradiation, all TLDs were within ± 10 %. 
Confirmation of reference absorbed dose result at simulator
The absorbed dose measured by the ionization chamber at the kilovoltage diagnostic beam was 1.00 ± 0.01 cGy.
TLD calibration results at the simulator
8 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were therefore not used as calibration dosimeters. The RCF value was calculated to be 0.01 nC / Gy. 5 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were discarded. 12 of the TLDs were within ± 10 % of the 1.00 cGy delivered as shown in Table 7 . For the 2.00 cGy irradiation, all TLDs were within ± 10 %. Overall, the results of the absorbed dose obtained when a separate RCF was generated for each beam quality showed that about 85 % of the TLDs produced results that were within ± 10 %. In the fluoroscopic diagnostic beam, 3 (20 %) of the TLDs deviated more than ± 10 %. This deviation could be due to experimental uncertainties. There was no significant deviation from linearity in the response when the TLDs were exposed to 2.00 Gy from the therapy beams and 2.00 cGy from the diagnostic beam.
In this study, separate calibrations of the TLDs in each beam quality have been employed to overcome energy dependence of the TLDs. The generation of a separate calibration factor (RCF) for each beam quality improved the overall result compared to a single calibration factor. No correction factors derived from published models 26 were applied in this work. The TLDs were also given a known absorbed dose in the 300 kV p therapy beam and then read using the RCF of the 180 kV p therapy beam. 60 % of the TLDs were within the ± 10 % of the absorbed dose delivered. This shows that the use of a single calibration factor used across medium energy beams could be investigated further.
In general, the results confirm that the TLDs are energy dependent. This result agrees with that of Krasa et al. 22 who showed that GR200A TLDs were energy dependent. The ratio of stopping powers or mass energy absorption coefficients of TLD to water is often used to describe variation of TLD response with varying photon energy 25 . However, there are other factors that affect the variation of TLD response with energy such as the thickness of the TL material, texture (i.e. roughness or smoothness of the TLD surface) of the TL material and doping (i.e. mixture of different materials), which may make it difficult to accurately predict the variation of TLD response with energy theoretically. In some cases, the use of monoenergetic photon beams along with mathematical models have been employed to predict the energy dependence of TLD response 23, 24 . Correction factors for different beam qualities have also been generated to compensate for this effect 26 . According to Kron et al. 23 , variation in TLD response could be due to the assumption that the response at low energies reduces exponentially whereas at medium energies, it varies according to the energy dependence from the photoelectric effect.
